Further, Spring et al. demonstrated that PTPRJ collaborates with EGFR to increase the activation of the downstream Src-dependent signaling pathway in aggressive breast cancer cells in order to promote tumor cell invasion and metastasis (Figure 2) [51]. Here, PTPRJ is linked to neoplasm.